超快速乳腺MRI中病灶强化时间相对于背景实质强化的研究:单中心回顾性研究
单中心回顾性研究纳入2019年7月至2023年4月连续行超快速乳腺MRI并随后接受MRI引导活检的124例患者124个病灶,评估病灶强化时间(TTE)与背景实质强化(BPE)TTE差值等动力学特征能否鉴别恶性与非恶性病灶;病灶TTE与BPE TTE差值每增加1秒,恶性比值增加5%(95%CI,2%-9%;p=.006),病灶相对于BPE出现强化越早与恶性可能性增加相关,形态学特征与恶性无关联。
要点
- 病灶TTE与BPE TTE差值每增加1秒,恶性比值增加5%(95%CI,2%-9%;p=.006)。
- BPE轻微或轻度者恶性比值是中度或明显者的11.69倍(95%CI,1.51-90.67)。
- 年龄较大与恶性可能性增加相关(p=.005),形态学特征与恶性无关联。
核心结论
- 超快速乳腺MRI上病灶相对于BPE出现强化越早,与恶性可能性增加相关;形态学特征与恶性无关联。
研究设计与样本
- 单中心回顾性研究,纳入2019年7月至2023年4月连续行超快速乳腺MRI并随后接受MRI引导活检的124例患者(平均年龄53岁,范围29-78岁)共124个病灶,从电子病历、影像报告和影像复核收集患者特征与病灶特征。
关键影像表现/征象
- 多数检查用于评估病变范围(47.6%[59/124]),其次为筛查(41.9%[52/124])。
- 患者以不均匀纤维腺体组织(58.1%[72/124])和轻度BPE(57.3%[71/124])为主。
- 124个病灶中21个(16.9%)为恶性,其中16个为浸润性癌、5个为导管原位癌。
诊断标准与关键数值
- 病灶TTE与BPE TTE差值每增加1秒,恶性比值增加5%(95%CI,2%-9%;p=.006)。
- BPE轻微或轻度者恶性比值是中度或明显者的11.69倍(95%CI,1.51-90.67)。
- 年龄较大与恶性可能性增加相关(p=.005),BPE较低与恶性可能性增加相关(p=.02)。
临床应用与阅片要点
- 病灶TTE与BPE TTE差值可能是评估恶性的有用参数,可能有助于减少不必要的活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Breast MRI is a sensitive tool for detecting small cancers. However, differentiating benign and malignant lesions remains challenging, particularly for foci. Studies evaluating other lesion types have identified ultrafast MRI (UFMRI) parameters associated with malignancy. OBJECTIVE. The purpose of this study was to determine whether kinetic features of UFMRI can differentiate malignant from nonmalignant foci. METHODS. This single-center retrospective study selected consecutive UFMRI examinations conducted from July 2019 to April 2023 with subsequently performed MRI-guided biopsy. Patient characteristics and lesion features were collected from the EMR, imaging reports, and imaging review. Focus and background parenchymal enhancement (BPE), time to enhancement (TTE), and the difference between focus TTE and BPE TTE were calculated. Associations with malignancy were assessed with univariable and multivariable logistic regression. RESULTS. A total of 124 patients (mean age, 53 years old; range, 29-78 years old) underwent biopsy of 124 foci. Sixty-four patients (51.6%) were postmenopausal, 71 (57.3%) had a personal history of breast cancer, and 81 (65.3%) had a family history of breast cancer. Of the 94 patients who underwent genetic testing, 33 (35.3%) had genetic mutations. Most examinations were performed to evaluate the extent of disease (47.6% [59/124]), followed by screening (41.9% [52/124]). Patients predominantly had heterogeneous fibroglandular tissue (58.1% [72/124]) and mild BPE (57.3% [71/124]). Of 124 lesions, 21 (16.9%) were malignant; of these, 16 were invasive and five were ductal carcinoma in situ. The odds of malignancy increased 5% with each 1-second increase in the difference between lesion TTE and BPE TTE (95% CI, 2-9%; p = .006). Older age and lower BPE were associated with increased likelihood of malignancy (p = .005 and p = .02, respectively). The odds of malignancy for patients with minimal or mild BPE were 11.69 times the odds for those with moderate or marked BPE (95% CI, 1.51-90.67). No other demographic or lesion characteristics were predictive of malignancy. CONCLUSION. Earlier visualization of a focus relative to BPE on UFMRI was associated with increased likelihood of malignancy; morphologic features showed no association with malignancy. CLINICAL IMPACT. The difference between focus TTE and BPE TTE may be a useful parameter for assessing malignancy, which could help reduce unnecessary biopsies.
引用
- Regen-Tuero HC, Gao Y, Li X, et al. Time to Enhancement of Foci Relative to Background Parenchymal Enhancement on Ultrafast Breast MRI: A Single-Center Retrospective Study. AJR Am J Roentgenol. 2025. PMID: 40202353. doi:10.2214/AJR.24.32309
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。